FCAG
CLVS

First Capital Advisors Group’s Clovis Oncology, Inc. CLVS Stock Holding History

First Capital Advisors Group’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-265
Closed -$14K – 818
2018
Q1 		$14K Buy
+265
New +$15.5K 0.01% 498

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

First Capital Advisors Group's CLVS Position: Q2 2018 in Review

First Capital Advisors Group sold out of Clovis Oncology, Inc. (CLVS) in Q2 2018, closing a stake of 265 shares — an estimated $14K sold.

First Capital Advisors Group first reported a position in CLVS in Q1 2018 and held it in 1 quarter. The position peaked at $14K in Q1 2018. 210 funds tracked by Wall St. Rank hold CLVS as of Q2 2018.

  • First Capital Advisors Group reported no remaining Clovis Oncology, Inc. position as of Q2 2018 after selling out during the quarter.
  • First Capital Advisors Group sold 265 Clovis Oncology, Inc. shares in Q2 2018, an estimated $14K.
  • First Capital Advisors Group first reported a position in Clovis Oncology, Inc. in Q1 2018 and held it in 1 quarter.
  • First Capital Advisors Group's Clovis Oncology, Inc. position peaked at $14K in Q1 2018.
  • 210 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2018.

Based on First Capital Advisors Group's 13F filing for Q2 2018, filed 30 Jul 2018.